1:tislelizumab

2 trials

Sponsors

The First Affiliated Hospital of Suzhou University, Department of Oncology, Jiangjin Hospital affiliated to Chongqing University

Conditions

Colorectal cancernewly diagnosed ovarian cancer

Phase 2

Neoadjuvant chemotherapy combined with tislelizumab in the treatment of newly diagnosed ovarian cancer: a single arm, single center, phase II study

Active, not recruitingChiCTR2000040760

The First Affiliated Hospital of Suzhou Universitynewly diagnosed ovarian cancer

Start: 2021-03-01Updated: 2021-07-05

A multicenter Phase II study of Tislelizumab in combination with bevacizumab and chemotherapy in second-line RAS mutated metastatic colorectal cancer

Active, not recruitingChiCTR2200062758

Department of Oncology, Jiangjin Hospital affiliated to Chongqing UniversityColorectal cancer

Start: 2022-08-18Updated: 2023-04-12